Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26


Concise review: Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells.

Visweswaran M, Arfuso F, Warrier S, Dharmarajan A.

Stem Cells. 2019 Oct 24. doi: 10.1002/stem.3101. [Epub ahead of print]


Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs.

Mandal S, Arfuso F, Sethi G, Dharmarajan A, Warrier S.

Int J Biochem Cell Biol. 2019 May;110:59-69. doi: 10.1016/j.biocel.2019.02.001. Epub 2019 Feb 6.


The expanding roles of long non-coding RNAs in the regulation of cancer stem cells.

Ma Z, Wang YY, Xin HW, Wang L, Arfuso F, Dharmarajan A, Kumar AP, Wang H, Tang FR, Warrier S, Tergaonkar V, Sethi G.

Int J Biochem Cell Biol. 2019 Mar;108:17-20. doi: 10.1016/j.biocel.2019.01.003. Epub 2019 Jan 7. Review.


Stemness, Pluripotentiality, and Wnt Antagonism: sFRP4, a Wnt antagonist Mediates Pluripotency and Stemness in Glioblastoma.

Bhuvanalakshmi G, Gamit N, Patil M, Arfuso F, Sethi G, Dharmarajan A, Kumar AP, Warrier S.

Cancers (Basel). 2018 Dec 27;11(1). pii: E25. doi: 10.3390/cancers11010025.


Pro-Apoptotic and Anti-Cancer Properties of Diosgenin: A Comprehensive and Critical Review.

Sethi G, Shanmugam MK, Warrier S, Merarchi M, Arfuso F, Kumar AP, Bishayee A.

Nutrients. 2018 May 19;10(5). pii: E645. doi: 10.3390/nu10050645. Review.


Correction: Role of novel histone modifications in cancer.

Shanmugam MK, Arfuso F, Arumugam S, Chinnathambi A, Bian J, Warrier S, Wang LZ, Kumar AP, Ahn KS, Sethi G, Lakshmanan M.

Oncotarget. 2018 Apr 10;9(27):19460. doi: 10.18632/oncotarget.25152. eCollection 2018 Apr 10.


Role of novel histone modifications in cancer.

Shanmugam MK, Arfuso F, Arumugam S, Chinnathambi A, Jinsong B, Warrier S, Wang LZ, Kumar AP, Ahn KS, Sethi G, Lakshmanan M.

Oncotarget. 2017 Dec 17;9(13):11414-11426. doi: 10.18632/oncotarget.23356. eCollection 2018 Feb 16. Review. Erratum in: Oncotarget. 2018 Apr 10;9(27):19460.


Epigenetic reprogramming converts human Wharton's jelly mesenchymal stem cells into functional cardiomyocytes by differential regulation of Wnt mediators.

Bhuvanalakshmi G, Arfuso F, Kumar AP, Dharmarajan A, Warrier S.

Stem Cell Res Ther. 2017 Aug 14;8(1):185. doi: 10.1186/s13287-017-0638-7.


'Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signalling.

Ong MS, Cai W, Yuan Y, Leong HC, Tan TZ, Mohammad A, You ML, Arfuso F, Goh BC, Warrier S, Sethi G, Tolwinski NS, Lobie PE, Yap CT, Hooi SC, Huang RY, Kumar AP.

Br J Pharmacol. 2017 Dec;174(24):4684-4700. doi: 10.1111/bph.13958. Epub 2017 Aug 23. Review.


Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer.

Shanmugam MK, Warrier S, Kumar AP, Sethi G, Arfuso F.

Curr Vasc Pharmacol. 2017;15(6):503-519. doi: 10.2174/1570161115666170713094319. Review.


Breast Cancer Stem-Like Cells Are Inhibited by Diosgenin, a Steroidal Saponin, by the Attenuation of the Wnt β-Catenin Signaling via the Wnt Antagonist Secreted Frizzled Related Protein-4.

Bhuvanalakshmi G, Basappa, Rangappa KS, Dharmarajan A, Sethi G, Kumar AP, Warrier S.

Front Pharmacol. 2017 Mar 20;8:124. doi: 10.3389/fphar.2017.00124. eCollection 2017.


sFRP-mediated Wnt sequestration as a potential therapeutic target for Alzheimer's disease.

Warrier S, Marimuthu R, Sekhar S, Bhuvanalakshmi G, Arfuso F, Das AK, Bhonde R, Martins R, Dharmarajan A.

Int J Biochem Cell Biol. 2016 Jun;75:104-11. doi: 10.1016/j.biocel.2016.04.002. Epub 2016 Apr 7. Review.


Secreted frizzled-related protein 4 inhibits glioma stem-like cells by reversing epithelial to mesenchymal transition, inducing apoptosis and decreasing cancer stem cell properties.

Bhuvanalakshmi G, Arfuso F, Millward M, Dharmarajan A, Warrier S.

PLoS One. 2015 Jun 1;10(6):e0127517. doi: 10.1371/journal.pone.0127517. eCollection 2015.


Generation of islet-like cell aggregates from human non-pancreatic cancer cell lines.

Kanafi MM, Mamidi MK, Sureshbabu SK, Shahani P, Bhawna C, Warrier SR, Bhonde R.

Biotechnol Lett. 2015 Jan;37(1):227-33. doi: 10.1007/s10529-014-1662-7. Epub 2014 Sep 26.


Multifunctional properties of chicken embryonic prenatal mesenchymal stem cells- pluripotency, plasticity, and tumor suppression.

Bhuvanalakshmi G, Arfuso F, Dharmarajan A, Warrier S.

Stem Cell Rev Rep. 2014 Dec;10(6):856-70. doi: 10.1007/s12015-014-9530-3. Review.


Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells.

Warrier S, Balu SK, Kumar AP, Millward M, Dharmarajan A.

Oncol Res. 2013;21(2):93-102. doi: 10.3727/096504013X13786659070154.


The preclinical efficacy, selectivity and pharmacologic profile of MK-5932, an insulin-sparing selective glucocorticoid receptor modulator.

Brandish PE, Anderson K, Baltus GA, Bai C, Bungard CJ, Bunting P, Byford A, Chiu CS, Cicmil M, Corcoran H, Euler D, Fisher JE, Gambone C, Hasbun-Manning M, Kuklin N, Landis E, Lifsted TQ, McElwee-Witmer S, McIntosh IS, Meissner RS, Miao J, Mitchell HJ, Musselman A, Schmidt A, Shin J, Szczerba P, Thompson CD, Tribouley C, Vogel RL, Warrier S, Hershey JC.

Eur J Pharmacol. 2014 Feb 5;724:102-11. doi: 10.1016/j.ejphar.2013.12.031. Epub 2013 Dec 27.


Secreted frizzled related proteins: Implications in cancers.

Surana R, Sikka S, Cai W, Shin EM, Warrier SR, Tan HJ, Arfuso F, Fox SA, Dharmarajan AM, Kumar AP.

Biochim Biophys Acta. 2014 Jan;1845(1):53-65. doi: 10.1016/j.bbcan.2013.11.004. Epub 2013 Dec 5. Review.


Study of chemoresistant CD133+ cancer stem cells from human glioblastoma cell line U138MG using multiple assays.

Warrier S, Pavanram P, Raina D, Arvind M.

Cell Biol Int. 2012;36(12):1137-43. doi: 10.1042/CBI20110539.


Evidence that estrogen directly and indirectly modulates C1 adrenergic bulbospinal neurons in the rostral ventrolateral medulla.

Wang G, Drake CT, Rozenblit M, Zhou P, Alves SE, Herrick SP, Hayashi S, Warrier S, Iadecola C, Milner TA.

Brain Res. 2006 Jun 13;1094(1):163-78. Epub 2006 May 11.


Supplemental Content

Loading ...
Support Center